Awaneesh Kumar, MD
Internal Medicine · Indianapolis, INNPI 1427557099
Payments from drug & device makers
What this record shows
This record is dominated by grants: $55,000 of the $68,351 with a category attached, or 80.5%. 25 manufacturers reported payments, led by Boston Scientific at 34.7% of the total. 2025 is the largest year on record at $63,552, more than ten times the $875 reported in 2021. Among internal medicine clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 128 payments — averaging $534.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$24K
- Medtronic$21K
- Abbott$17K
- Biotronik Inc.$3K
- Biosense Webster, Inc.$1K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$1K
- plus $2K from 19 others
What the payments were for
- Grants$55,00080%
- Travel & lodging$4,6197%
- Food & beverage$7,74111%
- Education$9911%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 13 | $23,699 |
| Medtronic | 8 | $20,615 |
| Abbott | 16 | $16,503 |
| Biotronik Inc. | 17 | $2,603 |
| Biosense Webster, Inc. | 10 | $1,466 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 20 | $1,136 |
| Inari Medical, Inc. | 5 | $585 |
| Actelion Pharmaceuticals US, Inc. | 4 | $444 |
| Johnson & Johnson | 6 | $303 |
| Abiomed | 3 | $296 |
| AstraZeneca | 7 | $215 |
| Cardiovascular Systems Inc. | 2 | $133 |
| Merck | 3 | $72 |
| Alnylam Pharmaceuticals Inc. | 2 | $55 |
| Teleflex LLC | 2 | $26 |
| Getinge USA Sales, LLC | 1 | $25 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| Sanofi | 1 | $22 |
| Boehringer Ingelheim | 1 | $22 |
| Siemens Medical Solutions USA, Inc. | 1 | $21 |
| Opsens Inc. | 1 | $21 |
| Cardiva Medical, Inc. | 1 | $18 |
| Terumo Medical Corporation | 1 | $17 |
| Scpharmaceuticals Inc. | 1 | $15 |
| Lexicon Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL EP$20,000
- TACTICATH$7,500
- ASSURITY$7,500
- GENERAL - THERAPIES$3,530
- Carto 3$1,226
- FLOWTRIEVER CATHETER, S$485
- CT THROMBECTOMY SYSTEM KIT$485
- UPTRAVI$353
- OPSUMIT$353
- ENSITE$338
- Impella$273
- LifeVest$271
- PRESSUREWIRE$263
- ENSITE PRECISION$207
- Micra$174
- OPTIS$164
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$138
- Farapulse$137
- XARELTO$135
- Optis Coronary Imaging System$132
How this compares
$68,351 in reported general payments places this provider in the 95th percentile of 1,747 internal medicine providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 39 | $33,560 |
| JardianceEmpagliflozin | 11 | $11,027 |
| Metoprolol Succinate | 21 | $416 |
| Losartan Potassium | 33 | $285 |
| Chlorthalidone | 14 | $240 |
| Rosuvastatin Calcium | 18 | $199 |
| Lisinopril | 18 | $166 |
| ClopidogrelClopidogrel Bisulfate | 16 | $163 |
| Furosemide | 25 | $158 |
| Atorvastatin Calcium | 19 | $135 |
| Amlodipine Besylate | 33 | $133 |
| Metoprolol Tartrate | 16 | $58 |
| Carvedilol | 19 | $50 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $22 | $11,02711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,747 internal medicine providers in Indiana.
Other internal medicine in Indianapolis
- Raj VuppalanchiIndianapolis$279K
- Napoleon MamintaIndianapolis$116K
- Allon FriedmanIndianapolis$111K
- John AyresIndianapolis$107K
- Justin FieldIndianapolis$49K
- Misty ShieldsIndianapolis$39K
- Volodymyr OliynykIndianapolis$38K
- Sapan BhutaIndianapolis$30K
- Azizullah BeranIndianapolis$29K
- Rachel WesterIndianapolis$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.